| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0003-4975(97)00543-2 |
| P698 | PubMed publication ID | 9262576 |
| P50 | author | Tetsuya Mitsudomi | Q37392624 |
| P2093 | author name string | Ohgami A | |
| Tsuda T | |||
| Osaki T | |||
| Oyama T | |||
| Nishida K | |||
| Yasumoto K | |||
| Sugio K | |||
| P2860 | cites work | A new international staging system for lung cancer | Q39729989 |
| The molecular biology of lung cancer pathogenesis | Q40891672 | ||
| Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction | Q40997423 | ||
| Detection of occult bone marrow micrometastases in patients with operable lung carcinoma | Q46291183 | ||
| Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer | Q58454765 | ||
| Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients | Q67542458 | ||
| Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance | Q67705312 | ||
| Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases | Q70989320 | ||
| p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival | Q71045346 | ||
| Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers | Q71093043 | ||
| Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer | Q71563606 | ||
| Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow | Q71669523 | ||
| Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor | Q71961895 | ||
| Establishment of Micrometastatic Carcinoma Cell Lines: a Novel Source of Tumor Cell Vaccines | Q72057569 | ||
| Frequency and Distribution of Occult Micrometastases in Lymph Nodes of Patients With Non-Small-Cell Lung Carcinoma | Q72072302 | ||
| Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells | Q72091018 | ||
| Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer | Q72301713 | ||
| Incidence of local recurrence and second primary tumors in resected stage I lung cancer | Q72395348 | ||
| Detection of micrometastases in patients with primary breast cancer | Q72567525 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| non-small-cell lung carcinoma | Q3658562 | ||
| P304 | page(s) | 363-367 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
| P1476 | title | Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer | |
| P478 | volume | 64 |
| Q37588628 | "The air got to it:" exploring a belief about surgery for lung cancer |
| Q35581371 | Adjuvant chemotherapy after complete resection for early stage NSCLC. |
| Q35142848 | Adjuvant therapy in completely resected non-small-cell lung cancer |
| Q35684081 | Basic treatment considerations: chemotherapy. |
| Q35604934 | Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis |
| Q43573296 | Bone marrow micrometastasis might not be a short-term predictor of survival in early stages non-small cell lung carcinoma |
| Q73503783 | Bone metastasis after a resection of stage I and II primary lung cancer |
| Q75448883 | Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma |
| Q37185823 | Clinical significance of disseminated tumour cells in non-small cell lung cancer |
| Q34740281 | Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology |
| Q35017957 | Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages |
| Q77376768 | Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival |
| Q40829473 | Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging |
| Q34951761 | Diagnosis and management of early lung cancer |
| Q73595241 | Evaluation of p53 alterations in occult lymph node metastases |
| Q52590470 | Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. |
| Q74513424 | Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer |
| Q74613850 | Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer |
| Q34997090 | Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer |
| Q73471599 | Immunostaining for detecting lymph node metastases in non-small cell lung cancer |
| Q73315621 | Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer |
| Q58454736 | MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence |
| Q34461762 | Micrometastases in non-small cell lung cancer (NSCLC). |
| Q42287142 | Micrometastasis in non-small-cell lung cancer: Detection and staging |
| Q34284347 | Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow |
| Q74569409 | Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications |
| Q33722441 | Molecular genetic characteristics of lung cancer--useful as real' tumor markers? |
| Q34274524 | Occult metastasis |
| Q52913139 | Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJS |
| Q43681814 | Postoperative adjuvant therapy for stage IB non-small-cell lung cancer |
| Q73615488 | Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study |
| Q44566523 | Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma |
| Q41878370 | T-box 3 overexpression is associated with poor prognosis of non-small cell lung cancer |
| Q34465167 | Technical aspects of minimal residual disease detection in carcinoma patients |
| Q74081745 | The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells |
| Q73308315 | The dream is almost over...don't worry, look ahead |
| Q34325213 | Treatment of stage I and II non-small-cell lung cancer |
| Q64884192 | [Anatomy, biology and concepts, pertaining to lung cancer stage classification]. |
| Q80352869 | [Micro-metastases and non-small cell lung cancer] |
| Q31143263 | cDNA microarray analysis of gene expression in pathologic Stage IA nonsmall cell lung carcinomas |
Search more.